Scott, S., Libby, C., & Hjelmeland, A. (2018). DDIS-15. A NOVEL DOPAMINE RECEPTOR 3 ANTAGONIST INHIBITS THE GROWTH OF PRIMARY AND TEMOZOLOMIDE RESISTANT GLIOBLASTOMA CELLS. Neuro Oncol.
Chicago-stil citatScott, Sarah, Catherine Libby, och Anita Hjelmeland. "DDIS-15. A NOVEL DOPAMINE RECEPTOR 3 ANTAGONIST INHIBITS THE GROWTH OF PRIMARY AND TEMOZOLOMIDE RESISTANT GLIOBLASTOMA CELLS." Neuro Oncol 2018.
MLA-referensScott, Sarah, Catherine Libby, och Anita Hjelmeland. "DDIS-15. A NOVEL DOPAMINE RECEPTOR 3 ANTAGONIST INHIBITS THE GROWTH OF PRIMARY AND TEMOZOLOMIDE RESISTANT GLIOBLASTOMA CELLS." Neuro Oncol 2018.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.